iRhythm Holdings (IRTC) Net Income towards Common Stockholders Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.60% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn | 54.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 54.62% |
| Dec 31, 2025 | 518.53% |
| Sep 30, 2025 | 88.71% |
| Jun 30, 2025 | 29.29% |
| Mar 31, 2025 | 32.77% |
| Dec 31, 2024 | 96.56% |
| Sep 30, 2024 | -70.31% |
| Jun 30, 2024 | -8.79% |
| Mar 31, 2024 | -16.77% |
| Dec 31, 2023 | -91.60% |
| Sep 30, 2023 | -26.41% |
| Jun 30, 2023 | 22.66% |
| Mar 31, 2023 | 22.72% |
| Dec 31, 2022 | 37.84% |
| Sep 30, 2022 | 9.61% |
| Jun 30, 2022 | -37.66% |
| Mar 31, 2022 | -82.18% |
| Dec 31, 2021 | -236.66% |
| Sep 30, 2021 | -407.40% |
| Jun 30, 2021 | 15.06% |
| Mar 31, 2021 | -206.44% |
| Dec 31, 2020 | 44.21% |
| Sep 30, 2020 | 74.43% |
| Jun 30, 2020 | -90.55% |
| Mar 31, 2020 | -9.88% |
| Dec 31, 2019 | -6.33% |
| Sep 30, 2019 | -88.06% |
| Jun 30, 2019 | 12.13% |
| Mar 31, 2019 | 25.79% |
| Dec 31, 2018 | -37.81% |
| Sep 30, 2018 | -42.10% |
| Jun 30, 2018 | -80.56% |
| Mar 31, 2018 | -99.69% |
| Dec 31, 2017 | -126.69% |
| Sep 30, 2017 | -97.09% |
| Jun 30, 2017 | -50.22% |
| Mar 31, 2017 | 1.75% |
| Dec 31, 2016 | 30.34% |
| Sep 30, 2016 | 39.30% |